Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2024-01-03 Audit Report / Informat…
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Results for the period ended 30 September 2023
Audit Report / Information Classification · 1% confidence The document explicitly states it contains the 'Annual Results for the period ended 30 September 2023' and includes an 'audited results' section, along with detailed financial and operational reviews (Pipeline, Fundraising, Summary and Outlook). The length (over 110,000 characters) confirms it is a comprehensive report, not just a brief announcement. Although it is filed via RNS (RNS Number: 4386Y), the content is clearly the full annual financial report, which aligns best with the 'Annual Report (Code: 10-K)' definition, even if the company might file a formal 10-K with the SEC later. Given the context of 'audited results' and the comprehensive nature, 10-K is the most appropriate classification for the content type, representing the annual performance disclosure. FY 2023
2024-01-03 English
NXP001 Update
Regulatory Filings Classification · 1% confidence The document is very short (2993 characters) and contains the header 'RNS Number : 0704X' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is approved to act as a Primary Information Provider. The content itself is a brief announcement regarding a milestone payment received under a licensing agreement (NXP001 Update). According to Rule 2 (The 'MENU VS MEAL' Rule), short announcements that convey specific, non-comprehensive corporate news and are distributed via an official news service like RNS are best classified as Regulatory Filings (RNS), especially when they don't fit perfectly into other specific categories like ER or DIV. While it is an announcement, RNS serves as the general regulatory filing/news category for such immediate updates.
2023-12-18 English
Notice of Allowance of NXP002 Patent in Japan
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 8813Q' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is a general regulatory announcement mechanism in the UK. The content announces a patent allowance in Japan for a drug asset (NXP002). Since this is a specific corporate event announcement distributed via the official regulatory news channel (RNS) and does not fit neatly into the more specific categories like ER, 10-K, or DIV, the most appropriate classification is the general regulatory announcement category. Document Length Check: The document length (3804 chars) is short, but the content is the announcement itself, not just a notice that a report is attached. Therefore, it is classified as the announcement rather than RPA (Report Publication Announcement). Given the source (RNS) and nature (corporate update/news), RNS is the best fit.
2023-10-23 English
NXP001 Update
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS filings are general regulatory announcements. The content discusses a specific corporate event—an update to a licensing agreement resulting in milestone payments—which is a material announcement typically disseminated via RNS. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate general regulatory category is RNS.
2023-09-18 English
Result of Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states it is the 'Result of Annual General Meeting' and details the voting outcomes for various resolutions presented to shareholders at that meeting. This directly corresponds to the definition of AGM Information (AGM-R). Although it contains voting results, the primary context is the outcome of the AGM itself, making AGM-R a more specific fit than DVA (Declaration of Voting Results & Voting Rights Announcements), which is often used for the formal declaration separate from the meeting announcement, or RNS (Regulatory Filings). Given the content is the results *from* the AGM, AGM-R is the best classification.
2023-08-24 English
Notice of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Notice of Annual General Meeting ("AGM")' and provides the date and location for the AGM. This directly corresponds to the definition of AGM Information (AGM-R). Although it is a notice, the content is the core information about the meeting itself, making AGM-R a better fit than a general RPA or RNS, which are usually announcements *about* the release of a document rather than the document's primary subject matter (the meeting notice). The document length is relatively short (2877 chars), but the content is the notice itself, not just an announcement that the notice is available.
2023-07-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.